Почетна › Steatotna bolest jetre › Arkanzas
Kliničke studije za Steatotna bolest jetre u državi Arkanzas
8 studija za Steatotna bolest jetre traži učesnike na lokacijama u državi Arkanzas.
Gradovi u državi Arkanzas
Zvanični tekst studije (na engleskom)
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Little Rock
- Akero Clinical Study Site, North Little Rock
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT06528314A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Arkansas Gastroenterology, P.A, Little Rock
- ARcare Center for Clinical Research, Little Rock
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 11. 2026. · NCT07288138A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Little Rock
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Little Rock
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07701993A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Little Rock
- 89bio Clinical Study Site, North Little Rock
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Little Rock
- 89bio Clinical Study Site, North Little Rock
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT06318169A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Arkansas Gastroenterology - North Little Rock, North Little Rock
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07165028A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Little Rock
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 7. 2026. · NCT07221227Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.